Spoken Alpha
Simulations Plus, Inc.
Simulations Plus provides software and consulting services to pharmaceutical, biotechnology, and related companies for drug discovery, development, clinical trials, and commercialization.
Simulations Plus, Inc is a Healthcare company operating in Health Information Services with a $372.9M market cap.
Most recent reported earnings: Q4 FY2026 (Oct 28, 2026).
22 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SLP.
$ curl https://api.spokenalpha.com/v1/companies/SLPFAQ
Spoken Alpha indexes SLP's earnings call transcripts at https://spokenalpha.com/companies/SLP. Each call links to attributed speakers and parsed analyst Q&A. Simulations Plus, Inc.'s own investor relations page is at https://www.simulations-plus.com/investorscorporate-profile/corporate-profile/.
Simulations Plus, Inc. (SLP) held its most recent earnings call on 2026-04-09, covering fiscal Q2 2026.
Simulations Plus, Inc. (SLP) operates in the Healthcare sector (Health Information Services industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 2026-10-28 | — | $0.16 | — | — | — | — | EODHD |
| Q3 FY2026 | 2026-07-08 | $0.30 | $0.23 | +30.4% | $21.9M | — | — | EODHD |
| Q2 FY2026 | 2026-04-08 | $0.35 | $0.31 | +12.9% | $24.3M | — | — | EODHD |
| Q1 FY2026 | 2026-01-07 | $0.13 | $0.20 | -35.0% | $18.4M | — | — | EODHD |
| Q4 FY2025 | 2025-10-21 | $0.10 | $0.10 | +1.4% | $17.5M | — | — | EODHD |
| Q3 FY2025 | 2025-07-13 | $0.45 | $0.25 | +80.0% | $20.4M | — | — | EODHD |
| Q2 FY2025 | 2025-04-02 | $0.31 | $0.26 | +19.2% | $22.4M | — | — | EODHD |
| Q1 FY2025 | 2025-01-06 | $0.17 | $0.17 | 0.0% | $18.9M | — | — | EODHD |
| Q4 FY2024 | 2024-10-22 | $0.04 | $0.03 | +33.3% | $18.7M | — | — | EODHD |
| Q3 FY2024 | 2024-07-01 | $0.19 | $0.16 | +18.8% | $18.5M | — | — | EODHD |
| Q2 FY2024 | 2024-04-02 | $0.20 | $0.18 | +11.1% | $18.3M | — | — | EODHD |
| Q1 FY2024 | 2024-01-02 | $0.10 | $0.11 | -9.1% | $14.5M | — | — | EODHD |
| Q4 FY2023 | 2023-10-24 | $0.02 | $0.18 | -88.9% | $15.6M | — | — | EODHD |
| Q3 FY2023 | 2023-07-05 | $0.21 | $0.21 | 0.0% | $16.2M | — | — | EODHD |
| Q2 FY2023 | 2023-04-04 | $0.21 | $0.18 | +16.7% | $15.8M | — | — | EODHD |
| Q1 FY2023 | 2023-01-03 | $0.07 | $0.10 | -30.0% | $12.0M | — | — | EODHD |
| Q4 FY2022 | 2022-10-25 | $0.04 | $0.07 | -42.9% | $11.7M | — | — | EODHD |
| Q3 FY2022 | 2022-07-05 | $0.20 | $0.17 | +17.6% | $15.0M | — | — | EODHD |
| Q2 FY2022 | 2022-04-05 | $0.21 | $0.12 | +75.0% | $14.8M | — | — | EODHD |
| Q1 FY2022 | 2022-01-05 | $0.15 | $0.09 | +66.7% | $12.4M | — | — | EODHD |
Source: EODHD. SLP reported actuals as published; sparse fields render as —.